Cytokine signature in chronic hepatitis C patients treated with peginterferon alpha 2A and ribavirin

被引：0
|
作者：
Neuman, M. G. [1 ,2 ,3 ]
Malkiewicz, I. M. [1 ]
Esguerra, R. [1 ,2 ,3 ]
Sha, K. [1 ,2 ,3 ,5 ]
Mazulli, T. [4 ,5 ]
Moussa, G. [4 ]
Morgan, M. [6 ,7 ]
Cohen, L. [6 ]
机构：
[1] MaRS, In Vitro Drug Safety & BioTechnol, Toronto, ON, Canada
[2] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
[3] Univ Toronto, Inst Drug Res, Toronto, ON, Canada
[4] Mt Sinai Hosp, Dept Virol & Microbiol, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med, Toronto, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Div Gastroenterol, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
来源：
CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [1] Chemokine, cytokine signature in chronic hepatitis C patients treated with peginterferon alpha 2a and ribavirin
    Neuman, Manuela G.
    Morgan, Mary
    Cohen, Lawrence B.
    GASTROENTEROLOGY, 2007, 132 (04) : A784 - A784
  • [2] Noninterventional Trial of Peginterferon α-2a in Combination with Ribavirin in Patients with Chronic Hepatitis C
    Bauer B.
    Dertinger S.
    Hubmann R.
    Pleiner-Duxneuner J.
    Journal für Gastroenterologische und Hepatologische Erkrankungen, 2019, 17 (3) : 68 - 74
  • [3] Early viral kinetics in patients with chronic hepatitis C genotype 2 or 3 treated with peginterferon α-2a and ribavirin
    Scherzer, Th-M.
    Staufer, K.
    Steindl-Munda, P.
    Holzmann, H.
    Ferenci, P.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S244 - S244
  • [4] Higher response rate from peginterferon alpha 2a plus ribavirin in chronic hepatitis C patients with hemophilia
    Kim, H. J.
    Lee, J. H.
    Lee, J. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A282 - A282
  • [5] HIGHER RESPONSE RATE FROM PEGINTERFERON ALPHA 2A PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS WITH HEMOPHILIA
    Sul, Hye Ryoung
    Kim, Hyung Joon
    Chung, Sun Joo
    Lee, Youn-Jae
    Park, Sung Jae
    Lee, Hyun Woong
    Yoo, Ki Young
    Hwang, Seung Jae
    Chung, Seung Moon
    Oh, Hyoung Chul
    Choi, Chang Hwan
    Kim, Jung Uk
    Do, Jae Hyuk
    Kim, Jae Kyu
    Chang, Sae Kyung
    Park, Sill Moo
    HEPATOLOGY, 2008, 48 (04) : 867A - 868A
  • [6] Toxicity of the treatment of chronic hepatitis C with peginterferon α (2a or 2b) plus ribavirin in patients not previously treated
    Marquez Peiro, Juan Francisco
    Valero Alcocer, Victoria Eugenia
    Suarez-Varela, Maria Morales
    Llopis Gonzalez, Agustin
    Perez Peiro, Carmen
    MEDICINA CLINICA, 2007, 129 (16): : 612 - 614
  • [7] Outcome of Retinopathy in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin
    Nilesh Mehta
    Uma K. Murthy
    Vivek Kaul
    Samuel Alpert
    Gerald Abruzzese
    Charles Teitelbaum
    Digestive Diseases and Sciences, 2010, 55 : 452 - 457
  • [8] Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
    Patrk, Ivana
    Morovic, Miro
    Markulin, Anamarija
    Patrk, Jogen
    DERMATOLOGY, 2014, 228 (01) : 42 - 46
  • [9] Outcome of Retinopathy in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin
    Mehta, Nilesh
    Murthy, Uma K.
    Kaul, Vivek
    Alpert, Samuel
    Abruzzese, Gerald
    Teitelbaum, Charles
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (02) : 452 - 457
  • [10] Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct acting antiviral
    Rutter, Karoline
    Beinhardt, Sandra
    Ferenci, Peter
    Dulic, Melisa
    Gschwantler, Michael
    Maieron, Andreas
    Laferl, Hermann
    Staettermayer, Albert
    Scherzer, Thomas-Matthias
    Strassl, Robert Paul
    Steindl-Munda, Petra E.
    Hofer, Harald
    HEPATOLOGY, 2012, 56 (06) : 1534 - 1534
12345